BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16160885)

  • 1. [Infectious disease surveillance based on the Protection against Infection Act in the German public health sector].
    Dreesman J; Benzler J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):979-89. PubMed ID: 16160885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complementary to notification required by the national Protection against Infection Act. State-specific mandatory infectious disease notification in Saxony-Anhalt].
    Oppermann H; Thriene B; Zaumseil S
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):990-7. PubMed ID: 16160886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences of the German public health service with the implementation of a new infections disease control act--results of focus group discussions].
    Krause G
    Gesundheitswesen; 2004; 66(8-9):522-7. PubMed ID: 15372354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The National Reference Centres and Reference Laboratories. Importance and tasks].
    Laude G; Ammon A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):998-1004. PubMed ID: 16160887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the 2004 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Benzler J; Krause G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Feb; 47(2):141-6. PubMed ID: 15205812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of public health service in prevention and control of infectious diseases in the Federal Republic of Germany. Tasks, structures and responsibilities--an overview].
    Wirtz A; Andres M; Gottschalk R; Stark S; Weber HJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):971-8. PubMed ID: 16160884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the 2007 edition of case definitions for the surveillance of notifiable infectious diseases in Germany].
    Poggensee G; Benzler J; Eckmanns T; Krause G;
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Dec; 49(12):1189-94. PubMed ID: 17149664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the Federal Government in the prevention and control of infectious diseases. Organizational structures, responsibilities and duties--an overview].
    Hamouda O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):963-70. PubMed ID: 16160883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timeliness in the German surveillance system for infectious diseases: Amendment of the infection protection act in 2013 decreased local reporting time to 1 day.
    Schumacher J; Diercke M; Salmon M; Czogiel I; Schumacher D; Claus H; Gilsdorf A
    PLoS One; 2017; 12(10):e0187037. PubMed ID: 29088243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mandatory notification of infectious diseases and agents in Germany: development and suggestions for improvement].
    Heudorf U; Gottschalk R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jun; 63(6):777-789. PubMed ID: 32399605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the duty of notification of infectious diseases via the Dutch Public Health Act].
    van Vliet JA; Haringhuizen GB; Timen A; Bijkerk P
    Ned Tijdschr Geneeskd; 2009; 153():B79. PubMed ID: 19818190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public Health Laboratories and the Affordable Care Act: What the New Health-Care System Means for Public Health Preparedness.
    Malcarney MB; Seiler N; Horton K
    Public Health Rep; 2015; 130(5):543-6. PubMed ID: 26327733
    [No Abstract]   [Full Text] [Related]  

  • 13. [First evaluation of the surveillance systems of notifiable diseases under the infectious disease control law in Germany].
    Krause G; Altmann D; Claus H; Hellenbrand W; Buchholz U; Hamouda O; Breuer T; Ammon A; Kramer M; ;
    Gesundheitswesen; 2003 Mar; 65 Suppl 1():S8-12. PubMed ID: 12649788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with outbreaks of nosocomial infections].
    Exner M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1432-43. PubMed ID: 23114443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001. Potentials and requirements].
    Werber D; Kramer MH; Buchholz U; Koch J; Weise E; Bockemühl J; Huppertz HI; Karch H; Zimmerhackl LB; Pulz M; Wildner M; Tschäpe H; Ammon A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1020-6. PubMed ID: 16927031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rare infectious diseases in Germany. Obligatory notification results].
    Schöneberg I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 May; 51(5):539-46. PubMed ID: 18696144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revised surveillance case definitions.
    Commun Dis Intell Q Rep; 2013 Jun; 37(2):E189-92. PubMed ID: 24340782
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surveillance of hygiene by local public health authorities - recommendations (not only) for the public health service in Rhineland-Palatinate].
    Rissland J
    Gesundheitswesen; 2011 Nov; 73(11):737-43. PubMed ID: 22113382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Appropriate administrative measures in the case of infectious diseases in public facilities].
    Schaks N
    Gesundheitswesen; 2013 Nov; 75(11):693-6. PubMed ID: 24163217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case definitions for diseases under national surveillance.
    Can Commun Dis Rep; 2000 May; 26 Suppl 3():i-iv 1-122. PubMed ID: 11055080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.